The stratification of CLL patients and implications for clinical practice
How durable are the responses of CLL patients to therapy?
The risk of infection for CLL patients receiving idelalisib
How to overcome resistance to new compounds in CLL
Advances in the treatment of chronic lymphocytic leukemia